4
Changes in Ownership
Akari Therapeutics Plc Filed Acc 0001493152-26-045366
CEO acquired 6,430 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gaslightwala Abizer · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-29 | Grant or award : show line 1 in the form | +6,430 | $9.72 | $62,500 | 14,107 | D |
Loading xslF345X06/ownership.xml…